Abstract
To develop an effective therapeutic approach to pancreatic ductal adenocarcinoma (PDAC), we focused on the antitumor mechanism of protein-bound polysaccharide (PSK) under hypoxia. PSK decreased proliferation in PDAC cells under hypoxia but not normoxia. PSK also showed anti-tumor effects in vivo, inhibited invasiveness of PDAC cells, and decreased the expression of HIF-1α and hedgehog (Hh) signaling-related molecules under hypoxia. Inhibition of HIF-1α and Hh signaling reduced proliferation and invasiveness in PDAC cells under hypoxia. In conclusion, we found new PSK-related pathways in invasiveness and proliferation in PDAC under hypoxia. PSK may be a promising therapeutic drug to treat refractory PDAC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibiotics, Antineoplastic / pharmacology
-
Carcinoma, Pancreatic Ductal / drug therapy*
-
Cell Cycle
-
Cell Hypoxia
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Female
-
Hedgehog Proteins / metabolism*
-
Humans
-
Hypoxia-Inducible Factor 1, alpha Subunit / biosynthesis
-
Hypoxia-Inducible Factor 1, alpha Subunit / genetics
-
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
-
Matrix Metalloproteinase 2 / biosynthesis
-
Matrix Metalloproteinase 9 / biosynthesis
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Neoplasm Invasiveness
-
Neoplasm Transplantation
-
Pancreatic Neoplasms / drug therapy*
-
Polysaccharides
-
Proteoglycans / pharmacology*
-
RNA Interference
-
RNA, Small Interfering
-
Signal Transduction
-
Transcription Factors / genetics
-
Xenograft Model Antitumor Assays
-
Zinc Finger Protein GLI1
Substances
-
Antibiotics, Antineoplastic
-
GLI1 protein, human
-
HIF1A protein, human
-
Hedgehog Proteins
-
Hypoxia-Inducible Factor 1, alpha Subunit
-
Polysaccharides
-
Proteoglycans
-
RNA, Small Interfering
-
Transcription Factors
-
Zinc Finger Protein GLI1
-
polysaccharide-K
-
Matrix Metalloproteinase 2
-
Matrix Metalloproteinase 9